About the Role
This role involves advancing patient care through science-based strategies and cross-functional collaboration in the field of amyloidosis, with a focus on improving health outcomes and supporting clinical teams.
Responsibilities
- Lead scientific engagement across healthcare teams specializing in amyloidosis
- Collaborate with clinical professionals to enhance patient diagnosis and treatment pathways
- Provide expert insights on disease state education and therapeutic interventions
- Support the integration of science-driven practices in multidisciplinary settings
- Develop educational materials for healthcare providers on rare disease management
- Facilitate communication between medical teams and scientific stakeholders
- Analyze clinical data to inform treatment strategies and care models
- Promote awareness of emerging research in amyloidosis care
- Engage in cross-functional initiatives to improve patient access to therapies
- Ensure alignment with regulatory and compliance standards in medical affairs
- Deliver presentations on clinical advancements to professional audiences
- Monitor trends in rare disease treatment and patient outcomes
- Partner with field teams to address unmet medical needs
- Coordinate with research institutions on data collection and dissemination
- Advocate for evidence-based medicine in amyloidosis treatment
- Support health economics and outcomes research initiatives
- Contribute to the development of medical strategy for rare disease programs
- Serve as a liaison between clinical sites and scientific networks
- Evaluate the impact of educational programs on care quality
- Maintain up-to-date knowledge of clinical guidelines and innovations
Compensation
Competitive salary and performance-based incentives
Work Arrangement
Hybrid with field-based responsibilities
Team
Part of a national medical affairs team focused on rare diseases
Location
Flint, MI – This role is based in Flint with regional travel expectations.
About the Role
This position supports a multidisciplinary approach to amyloidosis care, combining clinical insight with scientific expertise to improve patient outcomes.
Not available for this position
